2011 studies found for:    Open Studies | "Hematologic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Gulf Long-Term Follow-Up Study
Conditions: Cardiovascular Disease;   Hematologic Diseases;   Immunologic Disease;   Cancer;   Respiratory Function
Intervention:
22 Recruiting Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
Condition: Malignant Hematologic Disorder
Intervention: Other: No intervention
23 Recruiting The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases
Condition: Chronic Lymphoid Leukemia
Interventions: Drug: Cholecalciferol;   Drug: oleum neutralicum
24 Recruiting Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
Conditions: Acute Leukemias;   Burkitt's Lymphoma;   Chronic Myelogenous Leukemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Haploidentical stem cell transplant
25 Recruiting Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
Condition: Leukemia
Intervention:
26 Recruiting Occupational Status and Hematological Disease
Conditions: Chronic Myeloid Leukemia;   Chronic Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Chronic Thrombocytopenia;   Hodgkin Disease
Interventions: Behavioral: Study questionnaire;   Behavioral: SF-36 Questionnaire
27 Recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma;   Lymphoma, Primary Cutaneous Anaplastic Large Cell;   Lymphomatoid Papulosis;   Mycosis Fungoides;   Skin Lymphoma;   Cutaneous Lymphomas;   Lymphoma;   Hematologic Disorder
Intervention: Drug: SGN-35
28 Recruiting Dexamethasone Dyspnea Study
Conditions: Advanced Cancers;   Hematologic Disorder;   Solid Tumors
Interventions: Drug: Dexamethasone;   Drug: Placebo;   Behavioral: Questionnaires;   Device: Spirometer;   Other: Phone Calls
29 Recruiting Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
Condition: Hematologic Disorder
Interventions: Drug: Lenalidomide;   Biological: Influenza Vaccine;   Biological: Pneumovax Vaccine
30 Recruiting Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
Conditions: Hematological Diseases;   Thrombocytopenia
Interventions: Biological: MPs;   Drug: thrombopoietin (TPO) and interleukin-11
31 Recruiting Diamond Blackfan Anemia Registry (DBAR)
Conditions: Anemia;   Blood Disease
Intervention:
32 Recruiting Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
Conditions: Leukemia;   Lymphoma;   Blood Disorders;   Solid Tumors
Intervention: Drug: Ethanol lock therapy (ELT)
33 Recruiting Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
Condition: Blood Disorders
Interventions: Other: Patient-Centered Medical Home (PCMH);   Other: Standard Care
34 Recruiting Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
Conditions: Cancer;   Hematologic Disorders
Intervention: Other: Catheter Resistance Monitoring
35 Recruiting Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Conditions: Hematologic Disorders;   Hemoglobinopathies;   Immunodeficiencies
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Radiation: Total body irradiation;   Biological: Stem cell transplant;   Drug: Keppra
36 Unknown  Exercise Following Autologous Peripheral Blood Stem Cell Transplantation
Condition: Hematological Disease
Intervention: Other: Supervised exercise
37 Recruiting Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function
Conditions: Stem Cell Transplantation, Hematopoietic;   Poor Graft Function;   Hematological Diseases
Interventions: Biological: PBSC;   Biological: MSCs
38 Unknown  Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation
Conditions: Hematological Diseases;   Allogeneic Stem Cell Transplantation
Intervention: Drug: itraconazole
39 Recruiting Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation
Condition: Hematological Diseases
Intervention:
40 Recruiting Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
Conditions: Stem Cell Transplantation, Hematopoietic;   Mesenchymal Stem Cells;   Poor Graft Function;   Hematological Diseases
Intervention: Biological: Mesenchymal stem cells

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years